A 45-year-old healthy female presents to you with a 3-week history of nonbloody diarrhea. Initially she experienced 5 to 10 watery bowel movements per day with abdominal pain, low-grade fever, fatigue, and nausea. Although she has improved, she continues to have relapsing semiliquid stools every 2 days with abdominal pain and bloating. She is otherwise well and on no medications. She has not traveled recently, nor has she had contact with other symptomatic people. A stool C&S performed at a walk-in clinic was negative. You order a stool O&P. The laboratory reports the presence of Cyclospora cayetanensis oocysts. You decide not to treat but to see her again in a week, at which point her symptoms have improved considerably. A few weeks later, the media reports that BC is affected by a Cyclospora outbreak associated with imported fresh herbs.
Spring marks the start of the Cyclospora risk period in Canada (www.bccdc.ca/health-info/diseases-conditions/cyclospora-infection). Nearly every year for the last decade, BC has been affected by outbreaks of locally acquired Cyclospora infection (Table).
Cyclospora cayetanensis is a protozoan parasite that causes a protracted, relapsing gastrointestinal illness. Symptoms include frequent watery diarrhea, anorexia, abdominal cramps and bloating, nausea, flatulence, fever, and weight loss. Symptoms typically last 2 weeks to 2 months, and often wax and wane in intensity. Biliary disease, Guillain-Barré syndrome, and reactive arthritis have been reported following infection. Symptoms may resolve spontaneously, but patients with a severe or prolonged course and those who are immunocompromised should be treated with TMP/SMX or ciprofloxacin.
Cyclospora infection is diagnosed by stool ova and parasite (O&P) by microscopic examination. All BC laboratories use acid-fast staining to detect Cyclospora on all O&P samples. The Infectious Diarrhea – Guideline for Ordering Stool Specimens recommends O&P testing for patients with mild to moderate diarrhea with a likely infectious cause lasting more than 2 weeks. If initial results are negative and symptoms persist, a second O&P may be necessary.
People are infected by ingesting contaminated food or water. The infection is not spread from person to person. Infected individuals excrete oocysts in their feces. Oocysts require 7 to 15 days to sporulate in the environment before becoming infectious and may contaminate food where it is grown.
Cyclospora is not endemic in BC or Canada. Most infections are acquired from consuming contaminated food or water during travel to Central and South America or Asia in the spring and early summer. When infection occurs in a BC resident who did not travel, it is likely associated with imported food from an endemic country and leads to an outbreak investigation (Table).
Physicians play an important role in identifying outbreaks in the community. If patients present with acute but prolonged relapsing diarrhea, consider stool O&P testing even when no travel is reported. Cyclospora infection is reportable to public health. If a patient may be part of an outbreak or there is more than the usual number of patients with similar symptoms in a short period, report this to your local health unit or medical health officer for public health investigation.
—Eleni Galanis MD, MPH, FRCPC
—Linda Hoang, MD, MHSc, FRCPC
This article is the opinion of the BC Centre for Disease Control and has not been peer reviewed by the BCMJ Editorial Board.
2. Bugs & Drugs. Accessed 9 February 2018. www.bugsanddrugs.org/Home/Index/bdpage62B55D83D9294CF6AA576C8B045C139F.
3. BC Guidelines. Infectious diarrhea–guideline for ordering stool specimens. Accessed 26 February 2018. www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/infectious-diarrhea?keyword=infectious&keyword=diarrhea&keyword=guidelines.
Above is the information needed to cite this article in your paper or presentation. The International Committee
of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally
accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.
About the ICMJE and citation styles
The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.
An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.
BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:
- Only the first three authors are listed, followed by "et al."
- There is no period after the journal name.
- Page numbers are not abbreviated.
For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org